NCT00010452 2015-03-25
Study of Picibanil (OK432) Sclerotherapy in Children With Macrocystic Lymphatic Malformations
FDA Office of Orphan Products Development
Phase 2/3 Completed
FDA Office of Orphan Products Development
Fukushima Medical University
University of Yamanashi